- AuthorisedPhase I and Phase II (Integrated)- Other
A Phase 1b/2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Investigate A) the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of IM-101 in Adult Participants with Generalized Myasthenia Gravis, and B) the Efficacy and Safety of Treatment of IM-101 in Adult Participants with Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
This study is testing a new medicine, IM-101, for adults with Myasthenia Gravis (MG). It's looking at how safe it is and how well it works to improve symptoms of generalized and ocular MG.
For: Generalized Myasthenia Gravis and Ocular Myasthenia GravisBulgaria · Poland · Spain - Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase II, Randomized, Partially Blinded Study to Assess the Safety, Tolerability and Immunogenicity of Meningococcal Combined ABCWY Vaccine when Administered to Healthy Infants
This study is testing a new vaccine that aims to protect babies from serious illnesses like meningitis. The main goals are to see if it's safe, how well babies tolerate it, and if it helps their bodies build protection against these infections.
For: Infections · MeningococcalPoland · Spain · Germany